DRUG(DRUG)
DRUG
ANALYST COVERAGE3 analysts
BUY
▲ +82.0%upside to target
L $126.00
Med $136.50consensus
H $147.00PRICE
Prev Close
77.47
Open
76.49
Day Range72.44 – 79.03
72.44
79.03
52W Range23.18 – 123.75
23.18
123.75
52% of range
VOLUME & SIZE
Avg Volume
162.1K
FUNDAMENTALS
P/E Ratio
-37.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.80
Market-like
TECHNICAL
RSI (14)
45
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 97 days
Aug 24
Key MetricsTTM
Market Cap$794.70M
Revenue TTM$0.00
Net Income TTM-$19.84M
Free Cash Flow-$13.01M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-28.5%
Return on Assets-21.8%
Debt / Equity0.00
Current Ratio57.37
EPS TTM$-2.56
DRUG News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Stephen D. CollinsChief Medical Officer
Alex VasilkevichChief Operating Officer & Senior Scientific Officer
Ian McDonaldCo-Founder, Chief Executive Officer, President & Director
Ryan E. S. K. CheungCFO & Corporate Secretary
Emer LeahyConsultant
Jan Torleif PedersenChief Science Officer & Director